From: A multi-omics approach for identifying important pathways and genes in human cancer
Consensus cancer genes | All TCGA genes | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
C2.CP | C6 | C2.CP | C6 | ||||||||
# | Predictor | W | # | Predictor | W | # | Predictor | W | # | Predictor | W |
1 | TP53 | 0.784 | 1 | TP53 | 0.672 | 1 | KEAP1 | 0.766 | 1 | KEAP1 | 0.942 |
2 | SMARCA4 | 0.559 | 3 | MET (CNV) | 0.590 | 2 | TP53 | 0.484 | 2 | TP53 | 0.423 |
3 | MET (CNV) | 0.445 | 2 | SMARCA4 | 0.541 | 3 | SMARCA4 | 0.339 | 4 | KRAS | 0.397 |
4 | KRAS | 0.374 | 4 | KRAS | 0.507 | 4 | KRAS | 0.249 | 3 | SMARCA4 | 0.298 |
5 | SETD2 | 0.268 | 8 | EGFR (CNV) | 0.319 | 5 | STK11 | 0.171 | 8 | *BAGE2 | 0.209 |
6 | RBM10 | 0.263 | 25 | EGFR | 0.279 | 6 | *DST | 0.166 | 7 | *FRG1B | 0.148 |
7 | STK11 | 0.239 | 9 | FOXA1 (CNV) | 0.262 | 7 | *FRG1B | 0.145 | 13 | MET (CNV) | 0.146 |
8 | EGFR (CNV) | 0.220 | 10 | MYC (CNV) | 0.241 | 8 | *BAGE2 | 0.131 | 43 | *PKHD1 | 0.137 |
9 | FOXA1 (CNV) | 0.213 | 44 | EP300 (CNV) | 0.229 | 9 | *SPTA1 | 0.127 | 36 | EGFR | 0.130 |
10 | MYC (CNV) | 0.209 | 11 | SMARCA4 (CNV) | 0.227 | 10 | *ANK2 | 0.115 | 6 | *DST | 0.127 |